肌萎缩侧索硬化症：诊断、发病机制与治疗的最新思考
Amyotrophic Lateral Sclerosis: Recent Considerations for Diagnosis, Pathogenesis and Therapy.
作者信息
Eisen Andrew
机构信息
Division of Neurology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
出版信息
Brain Sci. 2025 May 13;15(5):498. doi: 10.3390/brainsci15050498.
Abstract
Amyotrophic lateral sclerosis (ALS/MND) is considered a uniquely human complex neurodegenerative disorder, presenting with a variety of clinical phenotypes, which include frontotemporal dementia [...].
摘要
肌萎缩侧索硬化症（ALS/MND）被认为是一种独特的人类复杂性神经退行性疾病，具有多种临床表型，其中包括额颞叶痴呆[...]。
相似文献
1
Amyotrophic Lateral Sclerosis: Recent Considerations for Diagnosis, Pathogenesis and Therapy.肌萎缩侧索硬化症：诊断、发病机制与治疗的最新思考
Brain Sci. 2025 May 13;15(5):498. doi: 10.3390/brainsci15050498.
2
TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者嗅黏膜中的TDP - 43播种活性
Mol Neurodegener. 2025 Apr 26;20(1):49. doi: 10.1186/s13024-025-00833-0.
3
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.额颞叶痴呆和肌萎缩侧索硬化中C9ORF72的研究路线图：C9ORF72额颞叶痴呆/肌萎缩侧索硬化峰会报告
Neurol Ther. 2023 Dec;12(6):1821-1843. doi: 10.1007/s40120-023-00548-8. Epub 2023 Oct 17.
4
Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.9p 染色体上 C9ORF72 突变引起的家族性额颞叶痴呆的临床和病理特征。
Brain. 2012 Mar;135(Pt 3):709-22. doi: 10.1093/brain/awr354. Epub 2012 Feb 17.
6
Alzheimer disease pathology in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的阿尔茨海默病病理
Acta Neuropathol. 2004 Jun;107(6):515-22. doi: 10.1007/s00401-004-0843-1. Epub 2004 Mar 16.
7
The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives.肌萎缩侧索硬化症-额颞叶变性谱系障碍中的语言研究：研究结果的系统回顾及新视角。
Neuropsychol Rev. 2018 Jun;28(2):251-268. doi: 10.1007/s11065-018-9375-7. Epub 2018 Apr 28.
8
A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.通过 CHCHD10 的参与，线粒体起源导致额颞叶痴呆和肌萎缩侧索硬化症。
Brain. 2014 Aug;137(Pt 8):2329-45. doi: 10.1093/brain/awu138. Epub 2014 Jun 16.
9
Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.肌萎缩侧索硬化症和额颞叶痴呆的常见分子途径。
Trends Mol Med. 2016 Sep;22(9):769-783. doi: 10.1016/j.molmed.2016.07.005. Epub 2016 Aug 4.
10
Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.法国肌萎缩侧索硬化症患者及合并肌萎缩侧索硬化症的额颞叶痴呆患者中核纤层蛋白3基因的遗传分析
Neurobiol Aging. 2014 Dec;35(12):2882.e13-2882.e15. doi: 10.1016/j.neurobiolaging.2014.07.016. Epub 2014 Jul 18.
本文引用的文献
1
Pathogenic TDP-43 in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的致病性TDP-43
Drug Discov Today. 2025 May;30(5):104351. doi: 10.1016/j.drudis.2025.104351. Epub 2025 Apr 4.
2
Exposing the exposome in aging.揭示衰老过程中的暴露组。
Nat Aging. 2025 Mar;5(3):340. doi: 10.1038/s43587-025-00845-x.
3
Amyotrophic lateral sclerosis represents corticomotoneuronal system failure.肌萎缩侧索硬化症代表皮质运动神经元系统功能衰竭。
Muscle Nerve. 2025 Apr;71(4):499-511. doi: 10.1002/mus.28290. Epub 2024 Nov 7.
4
Longitudinal analysis of glymphatic function in amyotrophic lateral sclerosis and primary lateral sclerosis.肌萎缩侧索硬化症和原发性侧索硬化症中脑淋巴系统功能的纵向分析。
Brain. 2024 Dec 3;147(12):4026-4032. doi: 10.1093/brain/awae288.
5
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis.一项1期概念验证研究，评估CTLA4-Ig与白细胞介素-2联合治疗肌萎缩侧索硬化症的安全性、耐受性和生物标志物反应。
Front Neurol. 2024 Jun 10;15:1415106. doi: 10.3389/fneur.2024.1415106. eCollection 2024.
6
Chronological and Biological Aging in Amyotrophic Lateral Sclerosis and the Potential of Senolytic Therapies.肌萎缩侧索硬化症中的时间和生物学衰老及衰老细胞清除疗法的潜力。
Cells. 2024 May 28;13(11):928. doi: 10.3390/cells13110928.
7
Sleep matters: Neurodegeneration spectrum heterogeneity, combustion and friction ultrafine particles, industrial nanoparticle pollution, and sleep disorders-Denial is not an option.睡眠至关重要：神经退行性变谱的异质性、燃烧与摩擦产生的超细颗粒、工业纳米颗粒污染以及睡眠障碍——否认并非可行之策。
Front Neurol. 2023 Feb 27;14:1117695. doi: 10.3389/fneur.2023.1117695. eCollection 2023.
8
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis.TDP-43 型肌萎缩侧索硬化症的神经病理学与神经解剖学
Curr Opin Neurol. 2022 Oct 1;35(5):660-671. doi: 10.1097/WCO.0000000000001098. Epub 2022 Aug 8.
9
Subject-specific features of excitation/inhibition profiles in neurodegenerative diseases.神经退行性疾病中兴奋/抑制谱的个体特异性特征。
Front Aging Neurosci. 2022 Aug 5;14:868342. doi: 10.3389/fnagi.2022.868342. eCollection 2022.
10
Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.安非他酮与巴氯芬（PXT864）联合应用于肌萎缩侧索硬化症的潜在新疗法。
J Neurosci Res. 2020 Dec;98(12):2435-2450. doi: 10.1002/jnr.24714. Epub 2020 Aug 19.
Zotero 插件